High-Dose Antithrombin III in Severe SepsisBrian Warren, Ivan Novák, Pavel Chalupa et al.|JAMA|2001Cited by 1.4k
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*Christian J. Wiedermann, Steven M. Opal, Johannes Hoffmann et al.|Critical Care Medicine|2006Cited by 188
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]Dale Rublee, Sigurd Knaub, Steven M. Opal et al.|Critical Care|2002Cited by 44